Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer

By sjmartinez • September 19, 2022

Liu F, Gai X, Wu Y, Zhang B, Wu X, Cheng R, Tang B, Shang K, Zhao N, Deng W, Chen J, Zhang Z, Gu S, Zheng L, Zhang H. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2202157119. doi: 10.1073/pnas.2202157119. Epub 2022 Sep 19. PMID: 36122209.

Tags: AKT2, CAD, Cardiology/Epi, liver cancer, Publications, pyrimidine synthesis, β-catenin

Association of Eicosanoids and Eicosanoid-Related Metabolites With Obesity and Cardiometabolic Traits

Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]

Dysglycaemia and Autonomic Dysfunction: The Diabetes Prevention Program Outcomes Study

Echouffo-Tcheugui JB, Liu X, Soliman EZ, Pi-Sunyer X, Golden SH, Dagogo-Jack S, White NH, Budoff M, Ibebuogu U, Darwin C, Knowler WC, Temprosa M; DPP[...]

Healthcare System Resilience and Adaptation: A 6-Year Analysis of Heart Failure Care in the Veterans Affairs System

Brownell NK, Inkelas M, Chen L, Leng M, Doan AAQ, Shannon E, Jackson N, Hsue P, Ong M, Yano E, Fonarow GC, Ziaeian B. Healthcare[...]